We cotransfected PART1‐sh with pcDNA‐JAK1 or JAK3 into A549 and H1650 cells to determine whether the regulation of PART1 on NSCLC progression was through JAK‐STAT signaling pathway. This evidence concerns the gene JAK1 and non-small cell lung carcinoma.